首页 | 本学科首页   官方微博 | 高级检索  
检索        


Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight,insulin secretion and action: A randomized controlled trial
Authors:Sun H Kim MD  Fahim Abbasi MD  Clara Nachmanoff  Konstantinos Stefanakis  Ajay Kumar PhD  Bhanu Kalra PhD  Gopal Savjani MS  Christos S Mantzoros MD
Institution:1. Division of Endocrinology, Gerontology and Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA;2. Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, California, USA

Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA;3. Department of Medicine, Boston VA Healthcare System and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA;4. Ansh Labs, Webster, Texas, USA

Abstract:
Keywords:clinical trial  control  GLP-1  GLP-1 analogue  glucagon  glycaemic  liraglutide
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号